*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************
Office of Sponsored Projects
Summary Sentence: A discussion panel on the NIH Director’s New Innovator Award.
Full Summary: OSP, in conjunction with IBB and the department of Chemistry & Biochemistry, announce a discussion panel on the NIH Director’s New Innovator Award.
The Office of Sponsored Programs, in conjunction Parker H. Petit Institute of Bioengineering and Biosciences and the Department of Chemistry & Biochemistry, are proud to announce a discussion panel on the NIH Director’s New Innovator Award.
Featured Panelists for the NIH
Director’s New Innovator Award:
Melissa L.
Kemp, Ph.D. is an Assistant Professor in the Wallace H. Coulter Dept. of
Biomedical Engineering. She took her Ph.D. from University of Washington in
2003. Dr. Kemp was a Postdoctoral fellow at the Massachusetts Institute of
Technology from 2003 to 2006. She received her B.S. from Massachusetts
Institute of Technology, 1997. Dr. Kemp’s areas of research include
systems biology in the context of cancer immunology, computational modeling of
intracellular metabolic and signaling pathways.
Manu O. Platt,
Ph.D. is an Assistant Professor in the Wallace H. Coulter Dept. of
Biomedical Engineering. He took his Ph.D. from Georgia Institute of Technology
and Emory University in 2006. Dr. Platt then completed a Postdoctoral
Fellowship at Massachusetts Institute of Technology from 2006 to 2008. He
received his B.S. from Morehouse College in 2001. Dr. Platt’s areas of
research encompasses tissue remodeling in arteries due to sickle cell disease or
HIV-infection, roles of proteases in tumor metastasis, and bone marrow-derived
stem cell based therapies.
Christine K. Payne, Ph.D. is an
Assistant Professor in Chemistry & Biochemistry. She received a NIH
Director’s New Innovator Award, 2009. She took her Ph.D. in Chemistry from the
University of California, Berkeley in 2003. Dr. Payne then completed an NIH
Postdoctoral Fellowship at Harvard University from 2003 to 2006. She received
her B.S. from the University of Chicago in 1998. Dr. Payne’s research is
to understand the mechanism of intracellular reactions in relation to the
cellular environment. Their research focuses on two aspects of cellular
regulation; spatial localization of enzymes in vesicles and diffusion within the
crowded environment of the cytosol.
The NIH Director's New Innovator
Award addresses two important goals: stimulating highly innovative research and
supporting promising new investigators. Many new investigators have
exceptionally innovative research ideas, but not the preliminary data required
to fare well in the traditional NIH peer review system. As part of NIH's
commitment to increasing opportunities for new scientists, it has created the
NIH Director's New Innovator Award to support exceptionally creative new
investigators who propose highly innovative projects that have the potential for
unusually high impact. This award complements ongoing efforts by NIH and its
institutes and centers to fund new investigators through R01 grants and other
mechanisms.
The NIH Director's New Innovator Award program is different
from traditional NIH grants in several ways. It is designed specifically to
support unusually creative new investigators with highly innovative research
ideas at an early stage of their career when they may lack the preliminary data
required for an R01 grant. The emphasis is on innovation and creativity;
preliminary data are not required, but may be included. No detailed, annual
budget is requested in the application. The procedure for evaluating applicants'
qualifications is distinct from the traditional NIH peer review “study section”
process and will emphasize the individual’s creativity, the innovativeness of
the research approaches, and the potential of the project, if successful, to
have a significant impact on an important biomedical or behavioral research
problem.
NIH Directors New Innovator
Award Application Due Date: October 14,
2011
Read RFA-RM-11-005 for detailed instructions on how to apply.
